Study of Pembrolizumab (MK-3475) Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (MK-3475-024/KEYNOTE-024)
Clinical trial NCT02142738 · COMPLETED
Trial details
- NCT number
- NCT02142738
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-25
- Primary completion
- 2016-05-09
- Enrollment
- 305
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.